Stem cell-derived Encapsulated Liver Tissue to treat liver failure without immunosuppression: technology maturation towards clinical translation
Stem cell-derived Encapsulated Liver Tissue to treat liver failure without immunosuppression: technology maturation towards clinical translation
干细胞衍生的包封肝组织无需免疫抑制即可治疗肝衰竭：技术成熟走向临床转化
批准号：
391206
负责人：
Paganelli Massimiliano
金额：
$36.22万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2021-09-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Liver failure is the common outcome of most progressive liver diseases. Patients with acute liver failure need to receive a liver transplant within days from the diagnosis, before their disease becomes irreversibly too severe. We developed an implantable
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heterologous stem cell therapy to treat acute liver failure in infants, children and adolescents without the need of immunosuppression
-
批准号：367713
-
项目类别：Operating Grants
-
资助金额：$5.46万
-
财政年份：2017
-
负责人：Paganelli Massimiliano
-
依托单位：
海外基金
